K. Papp

发表论文 541 篇 · 总被引 40217 次 · h-index 95

代表论文

Expert consensus on the systemic treatment of atopic dermatitis in special populations (2023 · Journal of the European Academy of Dermatology and Venereology · 被引 72)
Long-term safety and efficacy of risankizumab for the treatment of moderate-to-severe plaque psoriasis: Interim analysis of the LIMMitless open-label extension trial up to 5 years of follow-up. (2023 · Journal of American Academy of Dermatology · 被引 42)
Upadacitinib treatment withdrawal and retreatment in patients with moderate‐to‐severe atopic dermatitis: Results from a phase 2b, randomized, controlled trial (2023 · Journal of the European Academy of Dermatology and Venereology · 被引 29)
Safety and efficacy of mirikizumab versus secukinumab and placebo in the treatment of moderate-to-severe plaque psoriasis (OASIS-2): a phase 3, multicentre, randomised, double-blind study. (2023 · The Lancet Rheumatology · 被引 22)
Once-daily roflumilast foam 0.3% for scalp and body psoriasis: A randomized, double-blind, vehicle-controlled phase 2b study. (2023 · British Journal of Dermatology · 被引 21)
Comparison of risankizumab and apremilast for the treatment of adults with moderate plaque psoriasis eligible for systemic therapy: results from a randomized, open-label, assessor-blinded phase IV study (IMMpulse) (2023 · British Journal of Dermatology · 被引 17)